Care Access Research LLC
Pottsville, Pennsylvania, United States
Research institute in Scranton, Pennsylvania
201 Smallacombe Dr, Scranton, PA 18508
About Care Access Research LLC
"Patient Access Location; Research Institute; Alzheimer's Prevention Research"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
5
Janssen Research & Development, LLC
4
Exact Sciences Corporation
2
Pfizer
2
Arena Pharmaceuticals
1
Tobira Therapeutics, Inc.
1
Clinical Trials at Care Access Research LLC
During the past decade, Care Access Research LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on
average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)
2017-04-05
2021-03-09
Terminated
1,778
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
2018-06-18
2024-03-19
Recruiting
1,281
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
2018-07-18
2029-04-25
Recruiting
960
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-10-19
2025-03-18
Active, not recruiting
1,177
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
2019-07-23
2023-12-06
Active, not recruiting
1,100
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
2019-07-24
2021-04-29
Terminated
273
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Care Access Research LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials
sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Arena Pharmaceuticals"
with 2 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Care Access Research LLC"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Valneva Austria GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Care Access Research LLC
According to Clinical.Site data, the most researched conditions in "Care Access Research LLC" are
"Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "Colorectal Cancer" (2 trials), "Alzheimer Disease" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Care Access Research LLC" in a lesser frequency.
Clinical Trials Intervention Types at Care Access Research LLC
Most popular intervention types in "Care Access Research LLC" are "Drug" (12 trials), "Biological" (3 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Guselkumab" (3 trials), "Mirikizumab" (3 trials), "Golimumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Care Access Research LLC
The vast majority of trials in "Care Access Research LLC" are
15 trials for "All" genders.
Clinical Trials Status at Care Access Research LLC
Currently, there are NaN active trials in "Care Access Research LLC".
undefined are not yet recruiting,
8 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Care Access Research LLC,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Care Access Research LLC, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".